Cognitive and Imaging Differences After Proton and Photon Whole Brain Irradiation in a Preclinical Model.
Journal
International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
received:
11
01
2021
revised:
24
08
2021
accepted:
01
09
2021
pubmed:
13
9
2021
medline:
8
3
2022
entrez:
12
9
2021
Statut:
ppublish
Résumé
Compared with photon cranial radiation therapy (X-CRT), proton cranial radiation therapy (P-CRT) offers potential advantages in limiting radiation-induced sequalae in the treatment of pediatric brain tumors. This study aims to identify cognitive, functional magnetic resonance and positron emission tomography imaging markers and molecular differences between the radiation modalities. Juvenile rats received a single faction of 10 Gy (relative biological effectiveness-weighted dose) delivered with 6 MV X-CRT or at the midspread out Bragg peak of a 100 MeV P-CRT beam. At 3, 6, and 12 months post-CRT, executive function was measured using 5-choice serial reaction time task. At ∼12 months post-CRT, animals were imaged with Irradiated animals had cognitive impairment with a higher number of omissions and lower incorrect and premature responses compared with sham (P ≤ .05). The accuracy of the animals' X-CRT was less than that of sham (P ≤ .001). No significant difference in rates of cognitive change were found between the radiation modalities. At 12 months post-CRT, glucose metabolism was significantly higher than sham in X-CRT (P = .04) but not P-CRT. Using diffusion tensor imaging, P-CRT brains were found to have higher white matter volume and fiber lengths compared with sham (P < .03). Only X-CRT animals had higher apparent diffusion coefficient values compared with sham (P = .04). P-CRT animals had more connectomic changes compared with X-CRT. Correlative analysis identified several imaging features with cognitive performance. Furthermore, microgliosis (P < .05), astrogliosis (P < .01), and myelin thinning (P <.05) were observed in both radiation modalities, with X-CRT showing slightly more inflammation. Both P-CRT and X-CRT lead to neurocognitive changes compared with sham. Although no significant difference was observed in neuroinflammation between the irradiated groups, differences were found in late-term glucose metabolism and brain connectome. Our results indicate that despite relative biological effectiveness weighting of the proton dose there are still differential effects which warrants further investigation.
Identifiants
pubmed: 34509550
pii: S0360-3016(21)02786-3
doi: 10.1016/j.ijrobp.2021.09.005
pmc: PMC8748279
mid: NIHMS1739704
pii:
doi:
Substances chimiques
Protons
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
554-564Subventions
Organisme : NCI NIH HHS
ID : R01 CA208535
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA255596
Pays : United States
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Références
Nat Protoc. 2008;3(5):759-67
pubmed: 18451784
Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):446-53
pubmed: 25104071
J Clin Oncol. 2013 Oct 1;31(28):3494-500
pubmed: 23980078
Clin Transl Radiat Oncol. 2018 Jan 12;9:30-34
pubmed: 29594248
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
J Nucl Med. 2014 Nov;55(11):1805-10
pubmed: 25315244
Magn Reson Med. 2018 Oct;80(4):1614-1625
pubmed: 29427386
Neural Plast. 2016;2016:3259621
pubmed: 27242931
Front Neuroanat. 2013 Apr 09;7:3
pubmed: 23576961
Ann N Y Acad Sci. 2011 Apr;1224:109-125
pubmed: 21251014
J Cancer Surviv. 2020 Aug;14(4):483-493
pubmed: 32157609
Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1271-8
pubmed: 12128129
Nat Med. 2013 Sep;19(9):1184-9
pubmed: 23975025
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1143-52
pubmed: 25311260
Int J Prev Med. 2013 Jun;4(6):624-30
pubmed: 23930179
Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):54-63
pubmed: 26279024
Acta Neuropathol. 2016 Jun;131(6):821-31
pubmed: 27040285
Front Neurosci. 2013 Mar 12;7:31
pubmed: 23486659
Neuroimage. 2006 Feb 15;29(4):1058-65
pubmed: 16213163
Neurooncol Adv. 2019 May-Dec;1(1):vdz012
pubmed: 31608330
Exp Physiol. 2011 Apr;96(4):407-10
pubmed: 21123364
Neuroscientist. 2006 Dec;12(6):512-23
pubmed: 17079517
Neuro Oncol. 2012 Sep;14 Suppl 4:iv25-36
pubmed: 23095827
Neuroimage. 2010 Dec;53(4):1197-207
pubmed: 20600983
Neuro Oncol. 2005 Jan;7(1):12-9
pubmed: 15701278
Annu Rev Psychol. 2016;67:613-40
pubmed: 26393868
J Clin Oncol. 2020 Feb 10;38(5):454-461
pubmed: 31774710
J Neurotrauma. 2017 Mar 1;34(5):1074-1085
pubmed: 27554593
Neuro Oncol. 2018 Apr 9;20(5):695-704
pubmed: 29121259
Acta Oncol. 2017 Aug;56(8):1031-1042
pubmed: 28509599
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):407-21
pubmed: 12023146
Neuroimage. 2012 May 1;60(4):2096-106
pubmed: 22343126
Neuro Oncol. 2019 May 6;21(5):686-695
pubmed: 30753704
Radiother Oncol. 2017 Jul;124(1):89-97
pubmed: 28655455
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1508-1520
pubmed: 33307152
J Clin Oncol. 2016 Apr 1;34(10):1043-9
pubmed: 26811522